BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 30 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 448,101 | $322,633 | 0.08% |
| Long Focus Capital Management, LLC | 327,692 | $235,938 | 0.02% |
| Boxer Capital, LLC | 56,950 | $41,004 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 45,057 | $32,441 | 0.00% |
| Baker Brothers Advisors | 249,123 | $179,369 | 0.00% |
| SHUFRO ROSE & CO LLC | 12,941 | $9,318 | 0.00% |
| Parallel Advisors, LLC | 10 | $7 | 0.00% |
| MONEY CONCEPTS CAPITAL CORP | 264 | $190 | 0.00% |
| WELLS FARGO & COMPANY/MN | 781 | $562 | 0.00% |
| NORTHERN TRUST CORP | 10,981 | $7,906 | 0.00% |